Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
FUJIFILM
7 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Liposome Formulations
FUJIFILM Toyama Chemical Announces Completion of Japan’s First Manufacturing Facility for Commercial Liposome Formulations
PR-M12-19-NI-015
Partnership
Fujifilm Expands RIS Revenue Cycle Solutions With Availity Partnership
PR-M06-18-NI-033
Viral Vector
Flexible, Mobile, Modular: High-Containment Viral Vector Center of Excellence
PAP-Q2-18-CL-005
Expansion
Fujifilm Announces The Expansion Of Its Fill Finish Services
PR-M05-18-NI-095
Acquistion
FUJIFILM Expands into Bio-Medical Business with Acquisition
PR-M03-18-NI-103
Imaging
Fujifilm Debuts ASPIRE Bellus II, A New Multimodality Mammography Workstation
PR-M03-18-NI-041
Investment
FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.
PAO-M11-17-NI-029
